Logo image of CHYM

CHIME FINANCIAL INC-CL A (CHYM) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CHYM - US16935C1099 - Common Stock

21.13 USD
+0.96 (+4.76%)
Last: 11/28/2025, 8:19:05 PM
21.1 USD
-0.03 (-0.14%)
After Hours: 11/28/2025, 8:19:05 PM
Fundamental Rating

4

Taking everything into account, CHYM scores 4 out of 10 in our fundamental rating. CHYM was compared to 98 industry peers in the Financial Services industry. While CHYM has a great health rating, there are worries on its profitability. CHYM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year CHYM has reported negative net income.
CHYM Yearly Net Income VS EBIT VS OCF VS FCFCHYM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -100M -200M -300M -400M -500M

1.2 Ratios

CHYM has a Return On Assets of -1.29%. This is amonst the worse of the industry: CHYM underperforms 81.63% of its industry peers.
CHYM has a worse Return On Equity (-1.76%) than 76.53% of its industry peers.
Industry RankSector Rank
ROA -1.29%
ROE -1.76%
ROIC N/A
ROA(3y)-16.76%
ROA(5y)N/A
ROE(3y)-22.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CHYM Yearly ROA, ROE, ROICCHYM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

CHYM has a Gross Margin of 87.60%. This is amongst the best in the industry. CHYM outperforms 89.80% of its industry peers.
The Profit Margin and Operating Margin are not available for CHYM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CHYM Yearly Profit, Operating, Gross MarginsCHYM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 -40 60 80

9

2. Health

2.1 Basic Checks

CHYM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CHYM has about the same amount of shares outstanding.
There is no outstanding debt for CHYM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHYM Yearly Shares OutstandingCHYM Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 100M 200M 300M
CHYM Yearly Total Debt VS Total AssetsCHYM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B

2.2 Solvency

CHYM has an Altman-Z score of 8.38. This indicates that CHYM is financially healthy and has little risk of bankruptcy at the moment.
CHYM has a better Altman-Z score (8.38) than 90.82% of its industry peers.
CHYM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.38
ROIC/WACCN/A
WACC8.66%
CHYM Yearly LT Debt VS Equity VS FCFCHYM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

A Current Ratio of 4.94 indicates that CHYM has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.94, CHYM belongs to the best of the industry, outperforming 90.82% of the companies in the same industry.
CHYM has a Quick Ratio of 4.94. This indicates that CHYM is financially healthy and has no problem in meeting its short term obligations.
CHYM has a Quick ratio of 4.94. This is amongst the best in the industry. CHYM outperforms 90.82% of its industry peers.
Industry RankSector Rank
Current Ratio 4.94
Quick Ratio 4.94
CHYM Yearly Current Assets VS Current LiabilitesCHYM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.50% over the past year.
CHYM shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.88%.
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)30.88%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

CHYM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 62.00% yearly.
The Revenue is expected to grow by 25.23% on average over the next years. This is a very strong growth
EPS Next Y-5885.52%
EPS Next 2Y6.1%
EPS Next 3Y62%
EPS Next 5YN/A
Revenue Next Year31%
Revenue Next 2Y25.66%
Revenue Next 3Y22.94%
Revenue Next 5Y25.23%

3.3 Evolution

CHYM Yearly Revenue VS EstimatesCHYM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
CHYM Yearly EPS VS EstimatesCHYM Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 -1 -2 -3 -4

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CHYM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CHYM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CHYM Price Earnings VS Forward Price EarningsCHYM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CHYM Per share dataCHYM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as CHYM's earnings are expected to grow with 62.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.1%
EPS Next 3Y62%

0

5. Dividend

5.1 Amount

No dividends for CHYM!.
Industry RankSector Rank
Dividend Yield N/A

CHIME FINANCIAL INC-CL A

NASDAQ:CHYM (11/28/2025, 8:19:05 PM)

After market: 21.1 -0.03 (-0.14%)

21.13

+0.96 (+4.76%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)N/A N/A
Inst Owners70.36%
Inst Owner Change8.46%
Ins Owners2.65%
Ins Owner Change-13.19%
Market Cap7.91B
Revenue(TTM)1.67B
Net Income(TTM)-25.34M
Analysts80
Price Target31.86 (50.78%)
Short Float %3.62%
Short Ratio2.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.05%
Min EPS beat(2)2.81%
Max EPS beat(2)39.3%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.44%
Min Revenue beat(2)0.33%
Max Revenue beat(2)4.56%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-19.3%
PT rev (3m)-19.3%
EPS NQ rev (1m)-7.67%
EPS NQ rev (3m)14.46%
EPS NY rev (1m)-1.28%
EPS NY rev (3m)-8.45%
Revenue NQ rev (1m)1.45%
Revenue NQ rev (3m)2.49%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)0.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.73
P/FCF N/A
P/OCF N/A
P/B 5.48
P/tB 5.48
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.47
BVpS3.85
TBVpS3.85
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.29%
ROE -1.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.6%
FCFM N/A
ROA(3y)-16.76%
ROA(5y)N/A
ROE(3y)-22.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.94
Quick Ratio 4.94
Altman-Z 8.38
F-ScoreN/A
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)423.62%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.42%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-5885.52%
EPS Next 2Y6.1%
EPS Next 3Y62%
EPS Next 5YN/A
Revenue 1Y (TTM)30.88%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year31%
Revenue Next 2Y25.66%
Revenue Next 3Y22.94%
Revenue Next 5Y25.23%
EBIT growth 1Y73.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year236.03%
EBIT Next 3Y106.89%
EBIT Next 5Y103.57%
FCF growth 1Y126.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y140.96%
OCF growth 3YN/A
OCF growth 5YN/A

CHIME FINANCIAL INC-CL A / CHYM FAQ

What is the fundamental rating for CHYM stock?

ChartMill assigns a fundamental rating of 4 / 10 to CHYM.


What is the valuation status for CHYM stock?

ChartMill assigns a valuation rating of 1 / 10 to CHIME FINANCIAL INC-CL A (CHYM). This can be considered as Overvalued.


Can you provide the profitability details for CHIME FINANCIAL INC-CL A?

CHIME FINANCIAL INC-CL A (CHYM) has a profitability rating of 1 / 10.